For primary care physicians, these findings suggest that the choice of GLP-1 medication and its dosage can significantly influence the weight loss outcomes of their patients, Bartelt said
They are not inherently bad foods, and most are nutritionally valuable
The medication is altering hormone signaling in ways that not only suppress appetite but can also indirectly decrease energy availability, Dr
Tirzepatide, marketed for weight management as Zepbound, starts at 2.5 mg once weekly for four weeks an introductory dose meant to limit nausea, not to drive weight loss then steps up to 5 mg, and can be increased in 2.5 mg increments no sooner than every four weeks
There are several possible reasons why tirzepatide might be linked to back pain, even if it is not the direct cause